Search Results 171-180 of 16001 for Residual
Mayo Clinic: Less Invasive Surgery Detects Residual Breast Cancer in Lymph Nodes after Chemotherapy. mayonewsreleases. December 3, 2012. First · 1 · 2 · 3 · 4 .
"Now that we know that progenitor cells persist and lead to relapse after treatment, we can move quickly into clinical trials, measure this residual disease ...
... residual discarded skin specimens. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
The purpose of this study is to determine if microbiome DNA can be detected in the juice from the upper GI tract and that of the clinical residual specimens ...
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
Minimal residual disease (MRD) detection using circulating tumor DNA (ctDNA). MRD detection from proximal biofluids to anticipate cancer relapse ...
... residual disease (MRD) with clinical, radiographic, or pathologic progression at 12- and 24- months post-surgery in patients with HPV(-) head and neck cancer.
Rochester, Minn. The purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.
Surgical residual and biopsy tissue collection. Adult stem cell isolation. Expansion to 2D and 3D tissue-specific organoid cultures. Mycoplasma testing ...
Residual BE Prague >=C1 * 2.1.2. Residual BE >=M1 * 2.1.3. One or more islands of residual BE >=1 cm in diameter * 2.1.4. Any residual dysplasia in tubular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.